Role of therapeutic agents on repolarisation of tumour-associated macrophage to halt lung cancer progression.

Abstract:

:Tumour-associated macrophages (TAMs) represent as much as 50% of the solid mass in different types of human solid tumours including lung, breast, ovarian and pancreatic adenocarcinomas. The tumour microenvironment (TME) plays an important role in the polarisation of macrophages into the M1 phenotype, which is tumour-suppressive, or M2 phenotype, which is tumour promoting. Preclinical and clinical evidences suggest that TAMs are predominantly of the M2 phenotype that supports immune suppression, tumour growth, angiogenesis, metastasis and therapeutic resistance. Hence, significant attention has been focussed on the development of strategies for the modification of TAMs to halt lung cancer progression. The promotion of repolarisation from the M2 to the M1 subtype, or the prevention of M2 polarisation of TAMs in the stromal environment is potential approaches to reduce progression and metastasis of lung cancer. The focus of this article is an introduction to the development and evaluation of therapeutic agents that may halt lung cancer progression via the manipulation of macrophage polarisation. This article will address recent advances in the therapeutic efficacy of nanomedicine exploiting surface functionalisation of nanoparticles and will also consider future perspectives.

journal_name

J Drug Target

authors

Aldawsari HM,Gorain B,Alhakamy NA,Md S

doi

10.1080/1061186X.2019.1648478

subject

Has Abstract

pub_date

2020-02-01 00:00:00

pages

166-175

issue

2

eissn

1061-186X

issn

1029-2330

journal_volume

28

pub_type

杂志文章
  • Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice.

    abstract::Liposomal encapsulation of doxorubicin (DXR) improves tumor accumulation and reduces adverse effects. One possible strategy for further optimization of this delivery technology would be to design the liposome carrier to release its content within the tumor tissue in response to specific stimuli such as ultrasound (US)...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2010.551401

    authors: Hagtvet E,Evjen TJ,Olsen DR,Fossheim SL,Nilssen EA

    更新日期:2011-09-01 00:00:00

  • Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.

    abstract::Tissue plasminogen activator (tPA) is the only FDA approved medical treatment for the ischaemic stroke. However, it associates with some inevitable limitations, including: short therapeutic window, extremely short half-life and low penetration in large clots. Systemic administration may lead to complications such as h...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.1080/1061186X.2017.1365874

    authors: Zamanlu M,Farhoudi M,Eskandani M,Mahmoudi J,Barar J,Rafi M,Omidi Y

    更新日期:2018-02-01 00:00:00

  • Strategies for hepatic gene correction.

    abstract::Gene augmentation has been the paradigm in the majority of gene therapy protocols but in recent years the potential of repairing the mutated gene in situ by targeted gene correction has become a reality. In fact, targeted gene repair has many advantages over conventional replacement strategies, notably the possibility...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.1080/10611860290016739

    authors: Richardson P,Thoma C,Kren BT,Steer CJ

    更新日期:2002-03-01 00:00:00

  • Secure and effective gene delivery system of plasmid DNA coated by polynucleotide.

    abstract::Polynucleotides are anionic macromolecules which are expected to transfer into the targeted cells through specific uptake mechanisms. So, we developed polynucleotides coating complexes of plasmid DNA (pDNA) and polyethylenimine (PEI) for a secure and efficient gene delivery system and evaluated their usefulness. Polya...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2014.950665

    authors: Kodama Y,Ohkubo C,Kurosaki T,Egashira K,Sato K,Fumoto S,Nishida K,Higuchi N,Kitahara T,Nakamura T,Sasaki H

    更新日期:2015-01-01 00:00:00

  • Entrapment of cyclodextrin-drug complexes into liposomes: potential advantages in drug delivery.

    abstract::A novel concept in drug delivery discussed here, takes advantage of certain properties of the drug "containers" cyclodextrins and liposomes to combine them into a single system thus circumventing problems associated with both systems. The concept, entailing entrapment of water-soluble cyclodextrin-drug inclusion compl...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.3109/10611869408996821

    authors: McCormack B,Gregoriadis G

    更新日期:1994-01-01 00:00:00

  • Encapsulation of vancomycin and gentamicin within cationic liposomes for inhibition of growth of Staphylococcus epidermidis.

    abstract::Liposomes have been prepared from dipalmitoylphosphatidylcholine (DPPC), cholesterol (Chol) and dimethyldioctadecylammonium bromide (DDAB). The cationic vesicles adsorb to biofilms of the skin-associated bacteria Staphylococcus epidermidis, which have a negative charge. Encapsulation of the antibacterial drug vancomyc...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611869609015975

    authors: Sanderson NM,Jones MN

    更新日期:1996-01-01 00:00:00

  • Low-intensity light-induced paclitaxel release from lipid-based nano-delivery systems.

    abstract::Light-induced drug release has been explored as a strategy for externally modulating the release of drug from delivery systems. This study reports the development of a solid lipid nanoparticulate system (SLN) for paclitaxel (PTX), where photosensitizer-mediated oxidation of lipids was used as a mechanism for controlli...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186X.2019.1571066

    authors: Meerovich I,Nichols MG,Dash AK

    更新日期:2019-11-01 00:00:00

  • Multifunctional radiolabeled nanoparticles: strategies and novel classification of radiopharmaceuticals for cancer treatment.

    abstract::In this review, we emphasize the efforts on the development of radiolabeled nanoparticles (NPs) for cancer treatment, i.e. theranostic tools based on nanotechnology and nuclear medicine. Currently, radionuclide therapy remains to be an important treatment option. The ionizing radiation from radionuclides (not provided...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.3109/1061186X.2014.988216

    authors: Enrique MA,Mariana OR,Mirshojaei SF,Ahmadi A

    更新日期:2015-04-01 00:00:00

  • Targeting of N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin conjugate to the hepatocyte galactose-receptor in mice: visualisation and quantification by gamma scintigraphy as a basis for clinical targeting studies.

    abstract::N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers containing doxorubicin and galactosamine have been developed to target the hepatocyte galactose receptor with the aim of organ-specific chemotherapy of primary and metastatic liver disease. Previous biodistribution studies in rats and mice have used tyrosinamide inco...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611869308996068

    authors: Pimm MV,Perkins AC,Duncan R,Ulbrich K

    更新日期:1993-01-01 00:00:00

  • Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin.

    abstract:BACKGROUND:Treatment of late stage cancers has proven to be a very difficult task. Targeted therapy and combinatory drug administration may be the solution. PURPOSE:The study was performed to evaluate the therapeutic efficacy of PEG-PE micelles, co-loaded with curcumin (CUR) and doxorubicin (DOX), and targeted with an...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2013.840639

    authors: Abouzeid AH,Patel NR,Rachman IM,Senn S,Torchilin VP

    更新日期:2013-12-01 00:00:00

  • Non-covalent ligand conjugation to biotinylated DNA nanoparticles using TAT peptide genetically fused to monovalent streptavidin.

    abstract::DNA nanoparticles (DNA NPs), which self-assemble from DNA plasmids and poly-L-lysine (pLL)-polyethylene glycol (PEG) block copolymers, transfect several cell types in vitro and in vivo with minimal toxicity and immune response. To further enhance the gene transfer efficiency of DNA NP and control its tropism, we estab...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2012.712128

    authors: Sun W,Fletcher D,van Heeckeren RC,Davis PB

    更新日期:2012-09-01 00:00:00

  • Neuroprotective effects of a biodegradable poly(lactic-co-glycolic acid)-ginsenoside Rg3 nanoformulation: a potential nanotherapy for Alzheimer's disease?

    abstract::It is well established that overproduction and accumulation of the β-amyloid (Aβ) peptide 1-42 (Aβ(1-42)) is a trigger of the pathological cascade in Alzheimer's disease (AD) that manifests as cognitive impairment. Ginsenoside Rg3 is an important constituent of ginseng, plays an essential role in memory and improved c...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186X.2017.1354002

    authors: Aalinkeel R,Kutscher HL,Singh A,Cwiklinski K,Khechen N,Schwartz SA,Prasad PN,Mahajan SD

    更新日期:2018-02-01 00:00:00

  • Chloramphenicol-incorporated poly lactide-co-glycolide (PLGA) nanoparticles: formulation, characterization, technetium-99m labeling and biodistribution studies.

    abstract::Chloramphenicol-loaded (CHL) poly-d,l-lactic-co-glycolic acid (PLGA) nanoparticles (NPs) were prepared by emulsification solvent evaporation technique either by using polyvinyl alcohol (PVA) as emulsion stabilizer or polysorbate-80 (PS-80) as surfactant and characterised by transmission electron microscopy, zeta-poten...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860801899300

    authors: Halder KK,Mandal B,Debnath MC,Bera H,Ghosh LK,Gupta BK

    更新日期:2008-05-01 00:00:00

  • siRNA: an alternative treatment for diabetes and associated conditions.

    abstract::Diabetes is a condition that is not completely treatable but life of a diabetic patient can be smoothed by preventing or delaying the associate conditions like diabetic retinopathy, nephropathy, impaired wound healing process, etc. Apart from conventional methods to regulate diabetic condition, new techniques using si...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.1080/1061186X.2018.1476518

    authors: Shende P,Patel C

    更新日期:2019-02-01 00:00:00

  • Enhanced transfection of tumor cells in vivo using "Smart" pH-sensitive TAT-modified pegylated liposomes.

    abstract::Liposomes have been prepared loaded with DNA (plasmid encoding for the green fluorescent protein, GFP) and additionally modified with TATp and PEG, with PEG being attached to the liposome surface via both pH-sensitive hydrazone and non-pH-sensitive bonds. The pGFP-loaded liposomal preparations have been administered i...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860701498203

    authors: Kale AA,Torchilin VP

    更新日期:2007-08-01 00:00:00

  • Cyclodextrins for drug delivery.

    abstract::Cyclodextrins (CDs) are macrocyclic oligosaccharides composed of α(1,4)-linked glucopyranose subunits. These molecules possess a cage-like supramolecular structure, comparable with the structures of crown ethers, cryptands, spherands, cyclophanes, or calixarenes. However, it took 50 years to establish the molecular st...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.3109/10611861003622552

    authors: Laza-Knoerr AL,Gref R,Couvreur P

    更新日期:2010-11-01 00:00:00

  • Organ-based drug delivery.

    abstract::The phenomenal advances in pharmaceutical sciences over the last few decades have led to the development of new therapeutics like peptides, proteins, RNAs, DNAs and highly potent small molecules. Fruitful applications of these therapeutics have been challenged by several anatomical and physiological barriers that limi...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.1080/1061186X.2018.1437919

    authors: Alsaggar M,Liu D

    更新日期:2018-01-01 00:00:00

  • Phospholipids-based ultrasonic microbubbles for catechins encapsulation and ultrasound-triggered release.

    abstract:OBJECTIVE:The objective of this work was to examine the application of catechins-containing phospholipids-based ultrasonic microbubbles (PUM) in ultrasound-induced delivery. METHODS:Catechins-containing PUM were prepared by dissolving lyophilized PUM powder in catechins solution. Morphologic characteristics of catechi...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860802475696

    authors: Lu CT,Zhao YZ

    更新日期:2008-12-01 00:00:00

  • Cell-surface display of E7 antigen from human papillomavirus type-16 in Lactococcus lactis and in Lactobacillus plantarum using a new cell-wall anchor from lactobacilli.

    abstract::The human papillomavirus type-16 (HPV-16) E7 protein is considered a major viral oncoprotein involved in cervical cancer (CxCa) and a potential candidate for the development of a vaccine against this neoplasia. Here, two lactic acid bacteria (the model one Lactococcus lactis and a probiotic one Lactobacillus plantarum...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/10611860400024219

    authors: Cortes-Perez NG,Azevedo V,Alcocer-González JM,Rodriguez-Padilla C,Tamez-Guerra RS,Corthier G,Gruss A,Langella P,Bermúdez-Humarán LG

    更新日期:2005-02-01 00:00:00

  • Pieter Cullis: an outstanding lipid biophysicist, drug delivery scientist, educator, and entrepreneur.

    abstract::There are much said about Pieter Cullis in this special volume honoring him. He was the pioneer to study the role of hexagonal HII phase in membrane fusion and the one who applied this concept for the design of lipid nanoparticles. He was also the first to utilize remote loading techniques for the delivery of amphipat...

    journal_title:Journal of drug targeting

    pub_type: 传,历史文章,杂志文章

    doi:10.3109/1061186X.2016.1172590

    authors: Huang L,Miao L

    更新日期:2016-11-01 00:00:00

  • Internalization and subcellular fate of aptamer and peptide dual-functioned nanoparticles.

    abstract:PURPOSE:To evaluate the internalization and subcellular fate of AS1411 aptamer (for glioma targeting) and TGN peptide (for blood-brain barrier targeting)-modified nanoparticles (AsTNPs), which was important for optimizing targeted delivery systems and realizing the potential toxicity to cells. METHODS:Organelles were ...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2014.886038

    authors: Gao H,Yang Z,Zhang S,Pang Z,Jiang X

    更新日期:2014-06-01 00:00:00

  • Preparation and evaluation of once-a-day injectable microspheres of interferon alpha in rats.

    abstract::Gelatin microspheres (ms) and gelatin/BSA (bovine serum albumin) or gelatin/alginate ms were prepared by encapsulating fluorescein isothiocyanate (FITC) labeled dextran or interferon alpha (IFN-alpha). Ms were obtained by an emulsion-solvent-extraction method. Gelatin and gelatin/BSA ms were obtained by treating water...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611869908996851

    authors: Yoshikawa Y,Komuta Y,Nishihara T,Itoh Y,Yoshikawa H,Takada K

    更新日期:1999-01-01 00:00:00

  • Effect of applying modes of the polymer microneedle-roller on the permeation of L-ascorbic acid in rats.

    abstract::Despite the advantages of drug delivery through skin, transdermal drug delivery is only used with a small subset of drugs because most compounds cannot cross the skin at therapeutically useful rates. Recently, a new concept known as microneedle was introduced and could be used to pierce effectively to deliver drugs us...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611860903115274

    authors: You SK,Noh YW,Park HH,Han M,Lee SS,Shin SC,Cho CW

    更新日期:2010-01-01 00:00:00

  • Similar efficiency of DNA-liposome complexes and retrovirus-producing cells for HSV-tk suicide gene therapy of peritoneal carcinomatosis.

    abstract::Several experimental approaches have been tested for suicide gene delivery into tumor cells, including viral and non-viral vectors. In this study, we compared the efficiency of Herpes Simplex Virus type 1 thymidine kinase gene (HSV-tk) delivery by retrovirus-producing cells and DNA/liposome complexes for the treatment...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611860008996854

    authors: Princen F,Lechanteur C,Lopez M,Gielen J,Bours V,Merville MP

    更新日期:2000-01-01 00:00:00

  • Interactions of PC/Chol and PS/Chol liposomes with human cells in vitro.

    abstract::Interactions between phosphatidylcholine (PC) or phosphatidylserine (PS) liposomes and human umbilical vein endothelial cells (HUVEC) or human promyelocytic leukemia cells (HL60) were investigated. Pyramine encapsulating or rhodamine incorporating small unilamellar liposomes with mean diameters around 80 nm (demonstra...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611860008997910

    authors: Papadimitriou E,Antimisiaris SG

    更新日期:2000-01-01 00:00:00

  • Tweaking dendrimers and dendritic nanoparticles for controlled nano-bio interactions: potential nanocarriers for improved cancer targeting.

    abstract::Nanoparticles have shown great promise in the treatment of cancer, with a demonstrated potential in targeted drug delivery. Among a myriad of nanocarriers that have been recently developed, dendrimers have attracted a great deal of scientific interests due to their unique chemical and structural properties that allow ...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.3109/1061186X.2015.1052077

    authors: Bugno J,Hsu HJ,Hong S

    更新日期:2015-01-01 00:00:00

  • Liposomes in the treatment of infections.

    abstract::The use of liposomes in the treatment of severe infections is under investigation. Classical liposomes which localize in cells of the mononuclear phagocyte system (MPS) can be exploited in two ways. First for targeting of macrophage modulators such as muramyl peptides or IFN-gamma, to stimulate the cells of the MPS to...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章,评审

    doi:10.3109/10611869408996811

    authors: Bakker-Woudenberg IA,Storm G,Woodle MC

    更新日期:1994-01-01 00:00:00

  • Cascade catalytic nanoplatform for enhanced starvation and sonodynamic therapy.

    abstract::Background: Sonodynamic therapy (SDT) has emerged as an alternative to the traditional treatments of cancer. However, the oxygen consumption induced by SDT and glucose oxidase (GOx) mediated starvation therapy would worsen the hypoxic tumor environment, which further impeded therapeutic efficacy. Purpose: To develop a...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.1080/1061186X.2019.1641507

    authors: Zhang Y,Wang H,Jia X,Du S,Yin Y,Zhang X

    更新日期:2020-02-01 00:00:00

  • MAP-mediated nuclear delivery of a cargo protein.

    abstract::Radiolabeled cytochrome c (Cyt c), either as a free protein or as cell penetrating peptide (CPP)-conjugates, was tested for cellular uptake and nuclear transport in Human embryonic kidney 293 (HEK293) cells and HeLa cells. Conjugation of Cyt c with either the amphipathic peptide model amphipathic peptide (MAP) or the ...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/1061186X.2011.649481

    authors: Kenien R,Zaro JL,Shen WC

    更新日期:2012-05-01 00:00:00

  • Experiment on the factors for enhancing the susceptibility of cancer cells to chemotherapeutic drug by ultrasound microbubbles.

    abstract::The objective of this study was to investigate the factors for enhancing the susceptibility of cancer cells to chemotherapeutic drug by ultrasound microbubbles. Ultrasound (US) combined with phospholipid-based microbubbles (MB) was used to enhance the susceptibility of colon cancer cell line SWD-620 to anticancer drug...

    journal_title:Journal of drug targeting

    pub_type: 杂志文章

    doi:10.3109/10611860903434043

    authors: Zhao YZ,Gao HS,Zhou ZC,Tang QQ,Lu CT,Jin Z,Tian JL,Xu YY,Tian XQ,Wang L,Kong FL,Li XK,Huang PT,He HL,Wu Y

    更新日期:2010-07-01 00:00:00